ArticleAnnals of clinical case reports2025
Successful Recovery from Meningoencephalitis Associated with Archetype-like JC Virus in a Lung Transplant Recipient: Case Report and Review of the Literature.
Article in Annals of clinical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Meningoencephalitis due to JC polyomavirus (JCV) is rare and delays in diagnosis could lead to potentially fatal outcomes in immunosuppressed patients. We present a case of an HIV-negative lung transplant recipient who presented with neurological deficits, including aphasia and right-sided weakness. Brain imaging lacked demyelination usually diagnostic of progressive multifocal leukoencephalopathy (PML), the disease most often associated with JC virus, however cerebrospinal fluid (CSF) metagenomic analysis confirmed a high JC viral load, suggestive of JCV-associated meningoencephalitis. After reducing immunosuppression, the patient showed significant neurological improvement within three months and full recovery by 6 months. The JCV genome sequenced from patient's plasma and CSF were identical and resembled the "nonpathogenic" archetype in the non-coding region but shared homology in the coding region with the classically-considered neurotropic strains detected in those with PML. These findings suggest that mutations in the virus's noncoding region are not necessary for neuropathogenesis. We also review other cases of JCV-associated meningitis and encephalitis, which, in contrast to our case, were all fatal. Clinicians should consider JCV testing in immunosuppressed patients with encephalopathy and focal neurological deficits, even in the absence of significant brain radiographic abnormalities.
Indexed as
Identifiers
42111477PMC13155386What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.